NEW YORK (GenomeWeb News) – Labcyte has reeled in $5.3 million in Series D financing, which it plans to use to expand its acoustic low-volume liquid handling systems, the company said on Tuesday.

The new funding included backing from new investor GE Ventures' Heatlhymagination fund, and current investors, including Abingworth, Alloy Ventures, Cross Atlantic Partners, Delphi Ventures, H&Q Healthcare Investors, and H&Q Life Sciences Investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.